TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Renapharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 2,710 | 2,259 | 1,716 |
Financial expenses | 3 | 11 | 21 |
Earnings before taxes | 663 | 779 | 164 |
EBITDA | 710 | 901 | 273 |
Total assets | 3,337 | 2,541 | 2,133 |
Current assets | 1,747 | 951 | 753 |
Current liabilities | 693 | 205 | 532 |
Equity capital | 1,788 | 1,224 | 454 |
- share capital | 9 | 10 | 10 |
Employees (average) | 4 | 3 | 4 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 53.6% | 48.2% | 21.3% |
Turnover per employee | 678 | 753 | 429 |
Profit as a percentage of turnover | 24.5% | 34.5% | 9.6% |
Return on assets (ROA) | 20.0% | 31.1% | 8.7% |
Current ratio | 252.1% | 463.9% | 141.5% |
Return on equity (ROE) | 37.1% | 63.6% | 36.1% |
Change turnover | 634 | 575 | 201 |
Change turnover % | 31% | 34% | 13% |
Chg. No. of employees | 1 | -1 | 0 |
Chg. No. of employees % | 33% | -25% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.